EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T
Clinical trial NCT05521412 · RECRUITING
Trial details
- NCT number
- NCT05521412
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-29
- Primary completion
- 2025-08-03
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.